Kissei Pharmaceutical Co., Ltd.
Notice Regarding Status of Treasury Stock Acquisition
From September 1, 2026 to September 30, 2026, the Company conducted treasury stock acquisitions of its common stock through market purchases. The number of shares acquired was 106,400 shares, and the total acquisition amount was 426,244,500 yen. Acquisitions were made via listed market purchases; cumulative totals to date are 181,900 shares and 730,038,500 yen (as of September 30).
Key Figures
- 106,400 shares: Number of shares acquired
- 426,244,500 yen: Total acquisition amount
- 181,900 shares: Cumulative shares acquired (as of 9/30)
AI要約
Overview of Treasury Stock Acquisition
As treasury stock acquisitions under the Companies Act, the Company acquired its common stock through market purchases from September 1, 2026 to September 30, 2026. The total number of shares acquired was 106,400 shares, and the total acquisition amount was 426,244,500 yen. The acquisition method was market purchases (including discretionary market purchase agreements that include ToSTNeT-3), conducted through listed markets.
Cumulative Acquisition Status and Future Outlook
Based on the board resolution on May 11, 2026, the cap was set at 1,300,000 shares (3.14% of the total outstanding shares) and a maximum amount of 6,000,000,000 yen; cumulative acquisitions to date have reached 181,900 shares and a cumulative acquisition amount of 730,038,500 yen. The Company may continue market purchases within the determined period for additional acquisitions.
Kissei Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
